AAAAAA
Results: 26-50/105
Authors:
HANLEY JP
HAYES PC
LOWE GDO
LUDLAM CA
Citation: Jp. Hanley et al., HEPATOCELLULAR-CARCINOMA IN HEMOPHILIA, Thrombosis and haemostasis, 1997, pp. 1856-1856
Authors:
PROWSE C
DOW B
PELLY SJ
MCINTOSH E
READING S
LOWE GDO
GIBSON B
CACHIA P
THOMAS A
DENNIS R
LUDLAM CA
Citation: C. Prowse et al., STUDIES ON B19 PARVOVIRUS IN THE NORMAL AND HEMOPHILIC SCOTTISH POPULATION IN 1995, Thrombosis and haemostasis, 1997, pp. 1857-1857
Authors:
HAY CRM
LUDLAM CA
LOWE GDO
MAYNE EE
LEE RJ
PRESCOT RJ
LEE CA
Citation: Crm. Hay et al., THE EFFECT OF MONOCLONAL OR ION EXCHANGE-PURIFIED FACTOR-VIII CONCENTRATE ON HIV DISEASE PROGRESSION - A PROSPECTIVE-STUDY, Thrombosis and haemostasis, 1997, pp. 2078-2078
Authors:
SCOTT CM
STIRLING D
HANLEY JP
LUDLAM CA
Citation: Cm. Scott et al., PROTECTION FROM HIV-1 INFECTION BY TRANSFUSION IS CONFERRED BY HETEROZYGOSITY FOR A CCR-5 MUTATION, Thrombosis and haemostasis, 1997, pp. 2472-2472
Authors:
PEARSON H
STIRLING D
LUDLAM CA
Citation: H. Pearson et al., MAP OF TISSUE-SPECIFIC EXPRESSION OF FACTOR-VIII MESSENGER-RNA IN MURINE TISSUES, Thrombosis and haemostasis, 1997, pp. 2560-2560
Authors:
HAY CRM
NEGRIER C
LUDLAM CA
Citation: Crm. Hay et al., THE TREATMENT OF BLEEDING IN ACQUIRED HEMOPHILIA WITH RECOMBINANT FACTOR VIIA - A MULTICENTER STUDY, Thrombosis and haemostasis, 78(6), 1997, pp. 1463-1467
Authors:
NEWBY DE
WRIGHT RA
LUDLAM CA
FOX KAA
BOON NA
WEBB DJ
Citation: De. Newby et al., AN IN-VIVO MODEL FOR THE ASSESSMENT OF ACUTE FIBRINOLYTIC CAPACITY OFTHE ENDOTHELIUM, Thrombosis and haemostasis, 78(4), 1997, pp. 1242-1248
Authors:
RODDIE PH
LUDLAM CA
Citation: Ph. Roddie et Ca. Ludlam, RECOMBINANT COAGULATION-FACTORS, Blood reviews, 11(4), 1997, pp. 169-177
Authors:
LUDLAM CA
Citation: Ca. Ludlam, NEW-VARIANT CREUTZFELDT-JAKOB-DISEASE AND TREATMENT OF HEMOPHILIA, Lancet, 350(9092), 1997, pp. 1704-1704
Authors:
DARBY SC
EWART DW
GIANGRANDE PLF
SPOONER RJD
RIZZA CR
DUSHEIKO GM
LEE CA
LUDLAM CA
PRESTON FE
Citation: Sc. Darby et al., MORTALITY FROM LIVER-CANCER AND LIVER-DISEASE IN HEMOPHILIC MEN AND BOYS IN UK GIVEN BLOOD PRODUCTS CONTAMINATED WITH HEPATITIS-C, Lancet, 350(9089), 1997, pp. 1425-1431
Authors:
PROWSE C
LUDLAM CA
YAP PL
Citation: C. Prowse et al., HUMAN PARVOVIRUS B19 AND BLOOD PRODUCTS, Vox sanguinis, 72(1), 1997, pp. 1-10
Authors:
SMITH DB
CUCEANU N
DAVIDSON F
JARVIS LM
MOKILI JLK
HAMID S
LUDLAM CA
SIMMONDS P
Citation: Db. Smith et al., DISCRIMINATION OF HEPATITIS-G VIRUS GBV-C GEOGRAPHICAL VARIANTS BY ANALYSIS OF THE 5'-NONCODING REGION, Journal of General Virology, 78, 1997, pp. 1533-1542
Authors:
LUDLAM CA
HANLEY JP
HAYES PC
Citation: Ca. Ludlam et al., LIVER-BIOPSY IN HEMOPHILIA, British Journal of Haematology, 97(3), 1997, pp. 690-691
Authors:
CUNNINGHAM AJ
MCILROY J
RUSSELL A
MARQUIS J
GRINDEL JM
LUDLAM CA
STIRLING D
Citation: Aj. Cunningham et al., ANTISENSE UPTAKE IN MYELOID CELLS IS MEDIATED BY THE C3 COMPLEMENT RECEPTOR (MAC-1), Blood, 90(10), 1997, pp. 4595-4595
Authors:
NEWBY DE
BOON NA
WEBB DJ
LUDLAM CA
FOX KAA
WRIGHT RA
Citation: De. Newby et al., EFFECT OF INTRAARTERIAL SUBSTANCE-P ON THE RELEASE OF TISSUE-PLASMINOGEN ACTIVATOR IN THE HUMAN FOREARM, HEART, 75(5), 1996, pp. 13-13
Authors:
WATSON HG
LUDLAM CA
REBUS S
PEUTHERER JF
SIMMONDS P
Citation: Hg. Watson et al., HEPATITIS-B SEROLOGY AND DNA DETECTION IN MULTITRANSFUSED HEMOPHILIACS AND FACTOR-VIII AND FACTOR-IX CONCENTRATES, Haemophilia, 2(4), 1996, pp. 229-234
Authors:
CLELAND A
WATSON HG
ROBERTSON P
LUDLAM CA
BROWN AJL
Citation: A. Cleland et al., EVOLUTION OF ZIDOVUDINE RESISTANCE-ASSOCIATED GENOTYPES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(1), 1996, pp. 6-18
Authors:
OMALLEY T
LUDLAM CA
FOX KAA
ELTON RA
Citation: T. Omalley et al., MEASUREMENT OF PLATELET VOLUME USING A VARIETY OF DIFFERENT ANTICOAGULANT AND ANTIPLATELET MIXTURES, Blood coagulation & fibrinolysis, 7(4), 1996, pp. 431-436
Authors:
HAY CRM
COLVIN BT
LUDLAM CA
HILL FGH
PRESTON FE
Citation: Crm. Hay et al., RECOMMENDATIONS FOR THE TREATMENT OF FACTOR-VIII INHIBITORS - FROM THE UK-HEMOPHILIA-CENTER DIRECTORS ORGANIZATION INHIBITOR WORKING PARTY, Blood coagulation & fibrinolysis, 7(2), 1996, pp. 134-138
Authors:
PHILIPPOU H
ADAMI A
LANE DA
MACGREGOR IR
TUDDENHAM EGD
LOWE GDO
RUMLEY A
LUDLAM CA
Citation: H. Philippou et al., HIGH-PURITY FACTOR-IX AND PROTHROMBIN COMPLEX CONCENTRATE (PCC) - PHARMACOKINETICS AND EVIDENCE THAT FACTOR IXA IS THE THROMBOGENIC TRIGGERIN PCC, Thrombosis and haemostasis, 76(1), 1996, pp. 23-28
Authors:
JARVIS LM
DAVIDSON F
HANLEY JP
LUDLAM CA
SIMMONDS P
Citation: Lm. Jarvis et al., LOW-FREQUENCY OF PERSISTENT INFECTION WITH HGV OR GBV-C IN HEMOPHILIACS AND OTHER PLASMA PRODUCT USERS, Hepatology, 24(4), 1996, pp. 649-649
Authors:
JARVIS LM
DAVIDSON F
HANLEY JP
YAP PL
LUDLAM CA
SIMMONDS P
Citation: Lm. Jarvis et al., INFECTION WITH HEPATITIS-G VIRUS AMONG RECIPIENTS OF PLASMA PRODUCTS, Lancet, 348(9038), 1996, pp. 1352-1355
Authors:
HANLEY JP
JARVIS LM
SIMMONDS P
LUDLAM CA
Citation: Jp. Hanley et al., DEVELOPMENT OF ANTIINTERFERON ANTIBODIES AND BREAKTHROUGH HEPATITIS DURING TREATMENT FOR HCV INFECTION IN HEMOPHILIACS, British Journal of Haematology, 94(3), 1996, pp. 551-556
Authors:
HANLEY JP
JARVIS LM
ANDREWS J
DENNIS R
LEE R
SIMMONDS P
PIRIS J
HAYES P
LUDLAM CA
Citation: Jp. Hanley et al., INVESTIGATION OF CHRONIC HEPATITIS-C INFECTION IN INDIVIDUALS WITH HEMOPHILIA - ASSESSMENT OF INVASIVE AND NONINVASIVE METHODS, British Journal of Haematology, 94(1), 1996, pp. 159-165
Authors:
HANLEY JP
HAYDON GH
DAWKES R
HAYES PC
LUDLAM CA
Citation: Jp. Hanley et al., SERUM HYALURONIC-ACID - A USEFUL NONINVASIVE MARKER OF CIRRHOSIS IN HEMOPHILIACS WITH CHRONIC LIVER-DISEASE DUE TO HCV INFECTION, British Journal of Haematology, 93, 1996, pp. 224-224